Diagnostics & Research
The Diagnostics & Research industry has a total of 49 stocks, with a combined market cap of $742.72 billion, total revenue of $168.34 billion and a weighted average PE ratio of 46.40.
Market Cap
742.72B
Revenue
168.34B
Profits
16.01B
PE Ratio
46.40
Profit Margin
9.51%
Dividend Yield
0.21%
49 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 204.23B | 0.14% | 782,654 | 44.56B |
| 2 | DHR | Danaher Corporation | 152.28B | -0.55% | 1,003,219 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 50.68B | -1.54% | 155,373 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 35.95B | -1.92% | 974,245 | 6.95B |
| 5 | IQV | IQVIA Holdings Inc. | 31.94B | 0.43% | 495,792 | 16.31B |
| 6 | NTRA | Natera, Inc. | 29.36B | 4.53% | 512,691 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.01B | 0.34% | 63,305 | 4.03B |
| 8 | LH | Labcorp Holdings Inc. | 22.77B | -0.91% | 161,900 | 13.77B |
| 9 | DGX | Quest Diagnostics Incorporated | 21.20B | -0.08% | 476,684 | 10.85B |
| 10 | WAT | Waters Corporation | 20.42B | -10.03% | 974,728 | 3.11B |
| 11 | EXAS | Exact Sciences Corporation | 19.59B | 0.05% | 887,265 | 3.08B |
| 12 | ILMN | Illumina, Inc. | 18.00B | -1.63% | 666,375 | 4.34B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.07B | -1.30% | 116,534 | 2.36B |
| 14 | GH | Guardant Health, Inc. | 13.60B | 3.60% | 610,858 | 902.57M |
| 15 | RVTY | Revvity, Inc. | 11.53B | 0.09% | 338,637 | 2.86B |
| 16 | ICLR | ICON Public Limited Company | 11.51B | 0.05% | 528,993 | 8.10B |
| 17 | QGEN | Qiagen N.V. | 10.50B | - | 562,269 | 2.09B |
| 18 | CRL | Charles River Laboratories International, Inc. | 9.09B | -2.39% | 166,142 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 5.41B | 1.04% | 134,391 | 1.97B |
| 20 | SHC | Sotera Health Company | 4.96B | -1.58% | 264,745 | 1.15B |
| 21 | BLLN | BillionToOne, Inc. | 4.17B | 0.66% | 32,008 | 254.14M |
| 22 | GRAL | GRAIL, Inc. | 3.90B | -0.15% | 206,417 | 141.83M |
| 23 | TWST | Twist Bioscience Corporation | 2.94B | -2.50% | 364,812 | 391.56M |
| 24 | VCYT | Veracyte, Inc. | 2.88B | 0.75% | 139,904 | 495.14M |
| 25 | WGS | GeneDx Holdings Corp. | 2.62B | 7.51% | 321,899 | 402.19M |
| 26 | NEOG | Neogen Corporation | 2.31B | -1.85% | 464,735 | 880.32M |
| 27 | NEO | NeoGenomics, Inc. | 1.48B | 0.26% | 533,705 | 709.16M |
| 28 | CDNA | CareDx, Inc. | 1.03B | 2.47% | 131,285 | 358.00M |
| 29 | CSTL | Castle Biosciences, Inc. | 954.76M | -0.12% | 97,045 | 343.53M |
| 30 | OPK | OPKO Health, Inc. | 940.43M | -1.21% | 583,360 | 642.07M |
| 31 | FLGT | Fulgent Genetics, Inc. | 710.99M | -1.88% | 101,126 | 315.55M |
| 32 | PSNL | Personalis, Inc. | 699.78M | -2.17% | 329,870 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 473.53M | -0.78% | 155,363 | 825.30M |
| 34 | BNR | Burning Rock Biotech Limited | 363.16M | -0.79% | 3,808 | 75.75M |
| 35 | PRE | Prenetics Global Limited | 349.36M | 7.90% | 209,760 | 77.08M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 214.98M | 2.46% | 9,498 | 4.40M |
| 37 | MDXH | MDxHealth SA | 184.38M | 5.52% | 28,483 | 103.07M |
| 38 | FONR | FONAR Corporation | 121.56M | -0.03% | 16,782 | 105.43M |
| 39 | BDSX | Biodesix, Inc. | 80.07M | -3.03% | 50,998 | 80.17M |
| 40 | XGN | Exagen Inc. | 77.05M | -3.13% | 61,008 | 63.60M |
| 41 | PRPO | Precipio, Inc. | 35.78M | 1.79% | 9,210 | 22.80M |
| 42 | MBAI | Check-Cap Ltd. | 12.43M | 2.71% | 108,266 | - |
| 43 | NOTV | Inotiv, Inc. | 12.38M | -13.87% | 690,032 | 513.02M |
| 44 | MYNZ | Mainz Biomed N.V. | 7.40M | -13.59% | 666,326 | 659.94K |
| 45 | ADVB | Advanced Biomed Inc. | 5.90M | -0.78% | 5,015 | - |
| 46 | NDRA | ENDRA Life Sciences Inc. | 4.54M | 0.13% | 3,703 | - |
| 47 | BIAF | bioAffinity Technologies, Inc. | 3.83M | 0.09% | 46,880 | 6.78M |
| 48 | ISPC | iSpecimen Inc. | 3.11M | -3.52% | 1,340,520 | 3.35M |
| 49 | XWEL | XWELL, Inc. | 2.15M | -8.68% | 5,786,968 | 29.52M |